Additional file 4 of A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A

Attarian, Shahram; Young, Peter; Brannagan, Thomas H.; Adams, David; Van Damme, Philip; Thomas, Florian P.; Casanovas, Carlos; Tard, Céline; Walter, Maggie C.; Péréon, Yann; Walk, David; Stino, Amro; de Visser, Marianne; Verhamme, Camiel; Amato, Anthony; Carter, Gregory; Magy, Laurent; Statland, Jeffrey M.; Felice, Kevin

doi:10.6084/m9.figshare.16822597.v1

13023_2021_2040_MOESM4_ESM.docx (15.32 kB)

Additional file 4 of A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A

journal contribution

posted on 2021-10-17, 03:16 authored by Shahram Attarian, Peter Young, Thomas H. Brannagan, David Adams, Philip Van Damme, Florian P. Thomas, Carlos Casanovas, Céline Tard, Maggie C. Walter, Yann Péréon, David Walk, Amro Stino, Marianne de Visser, Camiel Verhamme, Anthony Amato, Gregory Carter, Laurent Magy, Jeffrey M. Statland, Kevin Felice

Additional file 4. Sensibility analysis: impact of age and sex on treatment effect.